Medical weight loss with peptide medications
A physician-supervised weight loss program that may include prescription peptide medications, such as GLP-1 medicines, alongside changes in nutrition and activity.
- Starts with
- A health review
- Follow-up
- Regular dose visits
- Support
- Nutrition and activity
Book online
Book a new patient visit
Choose an open day and time with John Beelitz, M.D. Your visit is confirmed as soon as you book.
Loading open times…
Already a patient? Call the office to book a follow-up visit. (561) 556-0272

Who may be evaluated
FDA-approved weight management medicines in this class are generally prescribed for adults with a body mass index (BMI) of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol. The physician reviews your history, medicines and goals before deciding whether a medication is appropriate.
How peptide medications work
Some prescription weight loss medicines are peptides, short chains of amino acids that act like hormones the body already makes. GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists are examples. They can slow stomach emptying, increase the feeling of fullness and reduce appetite.
Most are given as a once-weekly injection, starting at a low dose that is increased gradually.
What to expect
- An initial evaluation of your health history, current medicines and weight-related conditions
- Lab work or a records review when needed
- Regular follow-up visits to adjust the dose, review side effects and track progress
- Guidance on nutrition, protein and activity during treatment
Weight loss varies from person to person, and weight can return after a medication is stopped.
Risks and safety
Common side effects include nausea, vomiting, diarrhea, constipation and stomach pain, especially when the dose increases. More serious risks can include pancreatitis, gallbladder problems, low blood sugar when combined with some diabetes medicines, kidney problems from dehydration and allergic reactions.
Medicines in the GLP-1 class carry an FDA boxed warning about thyroid C-cell tumors. They should not be used by people with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN 2), and they are not used during pregnancy.
About compounded medications
Compounded versions of these medicines are not FDA-approved, and FDA does not review them for safety, effectiveness or quality before they are sold. Ask whether the medicine discussed for you is an FDA-approved product or a compounded preparation, and where it comes from.
Questions to ask Dr. Beelitz
Bring these to your visit.
- Which medication would you consider for me, and is it FDA-approved for weight management?
- How will my dose be adjusted, and how often are follow-up visits?
- What is the plan if side effects occur, or when I stop the medication?
- What will this cost, and does insurance cover it?
Talk with the office
Call to ask whether this may fit your situation, how scheduling works and which records to bring. You do not need to know which procedure you need before calling.
Call (561) 556-0272